6935.TWO Prince Pharmaceutical Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic Taiwan OTC Exchange
26.85 TWD
Close of Nov 6, 2026
24.70 33.23
Market cap
TWD 1.27B
P/E
7.7x
P/B
1.47x
ROE
11.5%
Dividend yield
1.83%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6935.TWO undervalued?

Graham number
Price26.85
Graham value37.78
Discount28.9%

6935.TWO trades 28.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Prince Pharmaceutical Co., Ltd. fundamental analysis

No fundamental analysis for Prince Pharmaceutical Co., Ltd. yet.

Prince Pharmaceutical Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin C tablets, vitamin B film-coated tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potass…

Full company profile